Matthew Goodman

R&D

LUCENT Biopharma's Medical Director Matthew Goodman, a doctor by training, specialises in late-phase Clinical Development and Medical Affairs.

News

The FDA has laid out a framework to use 'prior knowledge' on manufacturing, nonclinical, and clinical data to support cell and gene therapy filings.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.